AGI AGI

 

TIDMAGI 
 
RNS Number : 4716Y 
AGI Therapeutics plc 
03 September 2009 
 

AGI Therapeutics PLC 
 
 
Notification of Results 
 
 
AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality 
pharmaceutical company, will be announcing its interim results for the six 
months ended 30 June 2009 on Tuesday,  22  September  2009. 
 
 
 
 
Contact Information: 
 
 
+------------------------------------+------------------------------+ 
| AGI Therapeutics plc.              | Tel: +353 1 449 3254         | 
+------------------------------------+------------------------------+ 
| David Kelly, Chief Financial       |                              | 
| Officer                            |                              | 
+------------------------------------+------------------------------+ 
|                                    |                              | 
+------------------------------------+------------------------------+ 
| Financial Dynamics - UK            | Tel: +44 (0) 20 7269 7205    | 
+------------------------------------+------------------------------+ 
| Jonathan Birt/John Dineen          |                              | 
+------------------------------------+------------------------------+ 
|                                    |                              | 
+------------------------------------+------------------------------+ 
| Financial Dynamics - Ireland       | Tel: +353 (0) 1 66 33 602    | 
+------------------------------------+------------------------------+ 
| Niamh Lyons                        |                              | 
+------------------------------------+------------------------------+ 
|                                    |                              | 
+------------------------------------+------------------------------+ 
| Piper Jaffray Limited              | Tel: +44 (0) 20 3142 8700    | 
| Neil Mackison                      |                              | 
| Will Carnwath                      |                              | 
+------------------------------------+------------------------------+ 
|                                    |                              | 
+------------------------------------+------------------------------+ 
| Davy                               | Tel: +353 (1) 614 8761       | 
| John Frain                         |                              | 
+------------------------------------+------------------------------+ 
 
 
 
 
Notes to Editors: 
 
 
About AGI Therapeutics plc 
 
 
AGI is a speciality pharmaceutical company which is focused on the development 
and commercialisation of differentiated drug products for gastrointestinal (GI) 
diseases and disorders. AGI's common shares are listed on the Alternative 
Investment Market of the London Stock Exchange (AIM) and on the Irish Enterprise 
Exchange of the Irish Stock Market (IEX) as AGI. 
 
 
For further information please see www.agitherapeutics.com 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NORDGGGLGFGGLZM 
 

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025